Nikki Co., Ltd. (TYO:6042)

Regulus Therapeutics Revenue

Nikki had revenue of 2.05B JPY in the quarter ending June 30, 2025, a decrease of -21.73%. This brings the company's revenue in the last twelve months to 7.79B, down -17.88% year-over-year. In the fiscal year ending March 31, 2025, Nikki had annual revenue of 8.36B, down -10.64%.

• Revenue (ttm): 7.79B
• Revenue Growth: -17.88%
• P/S Ratio: 0.68
• Revenue / Employee: 15.52M
• Employees: 502
• Market Cap: 5.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	8.36B	-995.00M	-10.64%
Mar 31, 2024	9.36B	553.00M	6.28%
Mar 31, 2023	8.80B	-42.00M	-0.47%
Mar 31, 2022	8.84B	2.95B	50.03%
Mar 31, 2021	5.90B	-1.63B	-21.67%